Researchers are exploring delivering super-specific AAVs through the brain's natural waste disposal system, which can carry ...

The anti-amyloid drug is designed for a limited course, where patients can stop treatment once they reach a level of ...

The focus on treating people who have no cognitive impairment raises questions about how to implement testing for those at ...

After a promising Phase I read out on mKRAS-VAX in patients with hereditary cancer predisposition and pancreatic lesions, ...

The trial will include patients with relapsed or refractory B-cell malignancies, including patients who have received prior CAR T-cell therapies.

In an investigator-initiated trial, researchers will evaluate TPST-4003 in autoimmune disorders like myasthenia gravis and multiple sclerosis.

Telix Pharmaceuticals has opened a new radiopharmaceutical manufacturing and treatment facility in Melbourne, Australia, the company announced Thursday. Telix said the integrated facility in Melbourne ...

Primary care docs in Sweden diagnosed Alzheimer's with the same accuracy as dementia specialists when they had access to beta ...

The partnership gives Nucs AI access to Segmed's real-world imaging data, as it advances tools that can identify which prostate cancer patients will benefit from radiopharmaceuticals.

The results presented at AAIC had been highly anticipated since Biogen said it would advance the drug despite missing a Phase ...

The firm will seek regulatory approval to start clinical testing of its lead program in retinitis pigmentosa in early 2028 and then for an exon-skipping therapy for Usher syndrome 2.